Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B

NCT04135235 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT04135235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04135235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2019
Completion date
August 1, 2021
Enrollment
440 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b infection, high viral load